Kiran Naqvi

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Topics

Newly Diagnosed

Angiotensin Converting Enzyme

Allogeneic Hematopoietic Stem Cell Transplantation

Chronic Myeloid Leukemia

Top Venues

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Benjamin J Lee, Shawn P Griffin, Jean Doh, Alexandre Chan, Stefan O Ciurea, Deepa Jeyakumar, Angela G Fleischman, Kiran Naqvi, Nicholas R Pannunzio, Susan M O'Brien, Piyanuch Kongtim
HyperCVAD versus pegaspargase-containing regimens for Hispanic adults with newly diagnosed B-cell acute lymphoblastic leukemia. European journal of haematology (2023)
Imane Abou Dalle, Hagop M Kantarjian, Farhad Ravandi, Naval G Daver, Xuemei Wang, Elias J Jabbour, Zeev Estrov, Courtney D D DiNardo, Naveen Pemmaraju, Alessandra Ferrajoli, Nitin Jain, Sa A Wang, Nadya J Jammal, Gautam Borthakur, Kiran Naqvi, Sarah Pelletier, Sherry Pierce, Michael Andreeff, Guillermo Garcia Manero, Jorge E Cortes, Tapan Mahendra Kadia
Phase 2 study of lenalidomide maintenance for patients with high-risk acute myeloid leukemia in remission. Cancer 127 (11) (2021)
Kamal Chamoun, Hagop M Kantarjian, Xuemei Wang, Kiran Naqvi, Fleur Aung, Guillermo Garcia Manero, Gautam Borthakur, Elias J Jabbour, Tapan Mahendra Kadia, Naval G Daver, Courtney D D DiNardo, Nitin Jain, Marina Konopleva, Jorge Cortes, Farhad Ravandi, Musa Yilmaz
Unrecognized fluid overload during induction therapy increases morbidity in patients with acute promyelocytic leukemia. Cancer 125 (18) (2019)
Kiran Naqvi, Koiji Sasaki, Guillermo Montalban-Bravo, Ana Alfonso Pierola, Musa Yilmaz, Nicholas James Short, Rita Assi, Elias J Jabbour, Farhad Ravandi, Tapan Mahendra Kadia, Sherry Pierce, Koichi Takahashi, Graciela Nogueras Gonzalez, Rashmi Kanagal-Shamana, Keyur Patel, Kelly A Soltysiak, Hagop M Kantarjian, Guillermo Garcia Manero
Clonal hematopoiesis of indeterminate potential-associated mutations and risk of comorbidities in patients with myelodysplastic syndrome. Cancer 125 (13) (2019)
Kiran Naqvi, Elias J Jabbour, Jeffrey Skinner, Kristin Anderson, Sara Dellasala, Musa Yilmaz, Alessandra Ferrajoli, Prithviraj Bose, Philip Thompson, Yesid Alvarado, Nitin Jain, Koichi Takahashi, Jan Burger, Zeev Estrov, Gautam Borthakur, Naveen Pemmaraju, Shilpa Paul, Jorge Cortes, Hagop M Kantarjian
Long-term follow-up of lower dose dasatinib (50 mg daily) as frontline therapy in newly diagnosed chronic-phase chronic myeloid leukemia. Cancer 126 (1) (2019)
Koiji Sasaki, Hagop M Kantarjian, Tapan Mahendra Kadia, Keyur Patel, Sanam Loghavi, Guillermo Garcia Manero, Elias J Jabbour, Courtney D D DiNardo, Naveen Pemmaraju, Naval G Daver, Iman Abou Dalle, Nicholas James Short, Musa Yilmaz, Prithviraj Bose, Kiran Naqvi, Sherry Pierce, Fevzi Yalniz, Jorge E Cortes, Farhad Ravandi
Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3-internal tandem duplication mutation-positive acute myeloid leukemia. Cancer 125 (21) (2019)
Kiran Naqvi, Elias J Jabbour, Jeffrey Skinner, Musa Yilmaz, Alessandra Ferrajoli, Prithviraj Bose, Philip Thompson, Yesid Alvarado, Nitin Jain, Koichi Takahashi, Jan Burger, Zeev Estrov, Gautam Borthakur, Naveen Pemmaraju, Shilpa Paul, Jorge Cortes, Hagop M Kantarjian
Early results of lower dose dasatinib (50 mg daily) as frontline therapy for newly diagnosed chronic-phase chronic myeloid leukemia. Cancer 124 (13) (2018)
Prajwal C Boddu, Tapan Mahendra Kadia, Guillermo Garcia-Manero, Jorge Cortes, Mansour Alfayez, Gautam Borthakur, Marina Konopleva, Elias J Jabbour, Naval G Daver, Courtney D DiNardo, Kiran Naqvi, Musa Yilmaz, Nicholas J Short, Sherry Pierce, Hagop M Kantarjian, Farhad Ravandi
Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with NPM1 and FLT3-internal tandem duplication genotypes. Cancer 125 (7) (2018)
Kiran Naqvi, Hagop M Kantarjian
Reply to Starting with a lower daily dose of dasatinib in patients with chronic myeloid leukemia in chronic phase: Less is more, or is it? Cancer 124 (21) (2018)